Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-635-9 | CAS number: 70514-12-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute Oral Toxicity:
Acute oral toxicity of various paraffinic and naphthenic other lubricant base oils (IP 346 < 3%) in male and female rats was evaluated in API, 1982a by a single oral gavage administration of 5000 mg/kg body weight. The studies adhered to OECD Guideline 401, which is equivalent or similar to OECD Guideline 420. Based on the lack of clinical signs of toxicity or mortality, the acute oral LD50 for other lubricant base oils "sufficiently refined" and "insufficiently refined" is >5000 mg/kg.
Acute Dermal Toxicity:
Acute dermal toxicity of various paraffinic and naphthenic other lubricant base oils (IP 346 < 3%) in male and female rabbits was evaluated in a key Study by API, 1982a. At doses of either 2000 or 5000 mg/kg body weight. Based on the lack of adverse systemic effects or mortality, the acute dermal LD50 for other lubricant base oils "sufficiently refined" is >5000 mg/kg.
Acute Inhalation Toxicity:
Acute inhalation toxicity of various paraffinic and naphthenic other lubricant base oils (IP 346 < 3%) in male and female rats was evaluated in a key study by Exxon Biomedical Sciences, Inc, 1988a. An aerosol concentration of 5mg/L was found to have no effect. Additional supporting studies also evaluated the acute inhalation toxicity of greater and less than 3% OLBOs. The acute inhalation LC50 for other lubricant base oils is >5.0 mg/L.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 5 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Additional information
Acute oral toxicity:
Many key and supporting studies were available to assess the acute oral toxicity of other lubricant base oils (OLBO). Two studies were selected as key studies (API, 1982a and API, 1986a) and 14 were selected at supporting studies. The API 1982a study analyzed the acute oral toxic effects of paraffinic oil (CAS 64742-56-9), a sufficiently refined (IP 346 < 3%) OLBO. In this study, rats were administered a single neat oral dose (5 g/kg) via gavage of the respective OLBO. After 14 days of observation, no mortality or adverse clinical signs of toxicity were seen in either male of female rats. At necropsy, one female rat exhibited cystic masses on the spleen; otherwise, necropsy did not reveal any gross abnormalities in either male or female rats. The acute oral LD50for both studies was >5,000 mg/kg (5 g/kg). Based on this data, paraffinic oil and hydrotreated light naphthenic distillate are nontoxic when administered orally.
Supporting data from studies (API 1982b; 1982c; 1982d; 1982e; 1982f; 1982g 1986b; UBTL, 1983a; 1983b; 1983c; 1983d; 1983e; 1983f) conducted in rats demonstrate that other lubricant base oils (IP 346 < 3%) have acute LD50s >5000 mg/kg or >2000 mg/kg (NOTOX, 1994).
Acute Inhalation Toxicity:
Multiple key and supporting studies were available to assess the acute inhalation toxicity of other lubricant base oils. Two studies were selected as key studies (Exxon Biomedical Sciences, Inc., 1988a and API, 1987a) and 12 were selected as supporting studies. The Exxon Biomedical Sciences, Inc., 1988a study analyzed the toxic inhalation effects of a solvent extracted paraffinic oil, a sufficiently refined (IP 346 < 3%) OLBO. In this study, five male and five female young adult Sprague- Dawley rats were exposed by inhalation route to MRD-87-102 (a sufficiently refined lubricant base oil; IP 346 <3%) for four hours (whole body) at a concentration of 5.53 mg/L. Animals then were observed for 14 days. No mortality in either the control or exposed group was reported. There were no statistically significant differences in mean body weight between groups. Based on the results of the study, the four hour LC50for MRD-87-102 in rats by inhalation would appear to be greater than 5.53 mg/L.
Numerous acute inhalation studies have been made on other lubricant base oils having viscosities ranging from 10-30 cSt (Exxon Biomedical Sciences Inc., 1988b; 1988c, Mobil Oil Corporation 1984a; 1984b, Bioresearch Laboratories, Ltd., 1984a; 1984b; 1984c; 1984c; 1984d; 1984e; 1984f; 1984g; 1984h, Whitman et al. 1989). The majority of the studies show no or minimal lethality at high doses (> 5 mg/L). Only one sample
seems to be more toxic, API 83-12 (which results in LC50= 2.18 mg/L). This sample has higher aromatic content and slightly lower viscosity in comparison to the rest of the samples. Most likely the polycyclic aromatic compounds (PACs) content does not contribute to acute toxicity endpoints. The greater acute inhalation toxicity of this substance is more likely caused by the viscosity (10 cSt). Overall, the weight of evidence suggests that LC50values for this category of other lubricant base oils are greater than 5 mg/L.
Acute Dermal Toxicity:
Multiple studies were available to assess the acute dermal toxicity of other lubricant base oils. The API 1982a study analyzed the acute dermal toxic effects of solvent dewaxed light paraffinic oil (CAS 64742-56-9), a sufficiently refined (IP 346 < 3%) OLBO, at a dose of 5000 mg/kg bw/day for 24 hours on male and female rabbits. In this study, dermal administration at 5000 mg/kg did not result in any dermal irritation or signs of clinical toxicity. Gross necroscopy did not reveal any signs of systemic toxicity at the 5000 mg/kg dose level.
The dermal LD50was determined to be >5000 mg/kg bw.
Supporting data from studies (API 1982b; 1982c; 1982d; 1982e; 1982f; 1982g; and 1986b) conducted in rabbits have also demonstrated that sufficiently refined other lubricant base oils (IP 346 < 3%) have dermal LD50s of >5000 mg/kg bw.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
